Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials.
2023.11.27
For inquiries regarding this article
Nobuyuki Horita
Director
Chemotherapy Center, Yokohama City University Hospital
Yokohama, Japan
Director
Chemotherapy Center, Yokohama City University Hospital
Yokohama, Japan